• Contact Us
  • Indexing
  • Submit Manuscript
  • Open Access
  • Journals
  • Home
  • ISSN: 2373-9479
    Non-Surgical Approach to Ventriculo-Peritoneal Shunt Failure and Pneumoventricle
    Authors: Kourosh Tavanaiepour and George J. Kaptain
    Abstract: The introduction of air into components of a ventriculo-Peritoneal Shunt (VPS) is a recognized cause of shunt obstruction and failure.
    First Single Centre Experiece in Thoracic Outlet Syndrome
    Authors: Farid Yudoyono, Ferry Senjaya, Mira Yuniarti, Vonny Gunawan, Muhammad Z. Arifin and Ahmad Faried
    Abstract: Thoracic Outlet Syndrome (TOS) resulting from compression of irritation of the of the neurovascular structure at various level of the cervico-thoracic-brachial passages.
    Recent Articles
    Short Communication
    Cosamalon-Gan I, Villar Vega V, Cosamalon-Gan T, Cobo R, Mattos-Piaggio G, Garcia-Cosamalon J, and Vega JA*
    The German pathologist C.G. Schmorl was the first to systematically describe the normal structure and the degenerative changes of the human intervertebral disc, considering the age-related changes as primary degeneration. He established the terms of chondrosis, osteochondrosis, disc prolapse or herniation and intraosseus node. This paper briefly summarized the contribution of Schmorl to the knowledge of the intervertebral disc.
    Angel Horcajadas*, Isabel Ortiz*, Majed Katati, Ana Jorques, and Gonzalo Olivares
    Object: To evaluate the clinical and angiographic results as well as the costs of surgical treatment against endo-vascular treatment in a SAH in a paired series of patients.
    Methods: A retrospective study of a series of 78 SAH patients treated endovascularly (EV) or surgically (SC) and paired according to age, Hunt-Hess scale at admission, Fischer grade, aneurysm localization and follow-up time. A descriptive study was performed, as well as clinical results (Glasgow Outcome Scale, GOS, at 6 months), angiographic data (occlusion classification) and economic costs in each of the groups.
    Results: The mean age was 51.4 years (25-82) with a female predominance (7:10). The mean follow-up time was 37.3 months. Glasgow Outcome Scale (GOS) at 6 months was favorable (4-5) in 69.7% of the cases (bet-ter in the SC group). The average length of stay (ALOS) was 36.3 days (slightly higher in the EV group). Complete occlusion of the aneurysm was obtained in 80.0% of the patients in SC series and 47.3% in the EV series. 18.4% of the EV patients required retreatment. Costs of the SC treatment were slightly higher than the EV costs for the first admission (0.2% higher) but EV costs are considerably higher when the costs of follow-up and retreatment were added (13.4% more). The factors that made EV treatment more expensive were the costs of embolization material and retreatment.
    Conclusions: SC and EV treatment have similar clinical results; however SC treatment has greater stability and lower costs. Adequate selection of patients for treatment modality could save costs.
    Nonato MB*, Prandini MN, and De Muzio SDC
    Subarachnoid hemorrhage secondary to ruptured aneurysms is one of the major concerns of neurosurgeons when performing the currently available invasive rupture prevention treatments. Assuming that antiplatelet therapy not only reduces the formation of thrombi but also acts on the physiology of inflammation and decreases its progression, several studies have recently trying to establish a beneficial relationship of the aneurysms rupture prevention with antiplatelet therapy against the hypothesis of causing rates increase in aneurysms bleeding. The aim of the present study was to analyze the published literature on the relationship between antiplatelet therapy and its effect on the rupture of intracranial aneurysms.
  • Recent Articles
  • JSciMed Central welcomes back astronaut Scott Kelly and cosmonaut Mikhail Kornienko.
    Readmore...

    Wonder Women Tech not only disrupted the traditional conference model but innovatively changed the way conferences should be held.
    Readmore...

    JSciMed Central Peer-reviewed Open Access Journals
    10120 S Eastern Ave, Henderson,
    Nevada 89052, USA
    Tel: (702)-751-7806
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: JSMNS@jscimedcentral.com
    1455 Frazee Road, Suite 570
    San Diego, California 92108, USA
    Tel: (619)-373-8720
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: JSMNS@jscimedcentral.com
    About      |      Journals      |      Open Access      |      Special Issue Proposals      |      Guidelines      |      Submit Manuscript      |      Contacts
    Copyright © 2016 JSciMed Central All Rights Reserved
    Creative Commons Licence Open Access Publication by JSciMed Central is licensed under a Creative Commons Attribution 4.0 International License.
    Based on a work at https://jscimedcentral.com/. Permissions beyond the scope of this license may be available at https://creativecommons.org/.